148 stories found
The redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring users to understand NIH's organizational structure
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations and is frequently mentioned in prize predictions.
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the fastest-growing Ebola outbreak in history.
Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and pharmacists aren’t thrilled.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers
Covered by STAT News, The Guardian – Health. Pennsylvania officials count four measles-related deaths this year. The CDC only counts two.
A doctor’s request to marathons: Let’s make evidence-based medical plans — especially for extreme heat.
The law has to catch up on the 340B drug discount program, writes a pharmacist.
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
"Highlighting a ton of open questions": Top journal's special issue on women's health examines the latest discoveries on chronic pain and menopause.
Why have so many Americans lost trust in science? And what's the deal with a new gene-editing lawsuit? Find out on this week's episode of "The Readout LOUD" podcast.
Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.
Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.
Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to question what MAHA has become.
In this edition of STAT Health Tech: A California insurer on how it may replicate Medicare's tech-enabled chronic-care experiment.
WASHINGTON — The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to only four companies. The Global Benchmark for…
DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can remain in the U.S.